The study and its comparison
A twelve-week trial randomized 50 adults with trichotillomania to N-acetylcysteine, 1,200–2,400 mg daily, or placebo. Hair-pulling scores improved more with NAC; a significant difference first appeared after nine weeks. [1][2]
A separate twelve-week trial in 39 children and adolescents aged 8–17 found no significant benefit on primary or secondary outcomes. Responder proportions were 25 percent with NAC and 21 percent with placebo. [1][2]
What the finding establishes
The adult result does not establish pediatric efficacy or a guaranteed response date. These were small studies of diagnosed hair pulling, not every cause of hair loss. Funding and conflicts were not established from the retrieved abstracts. Treatment should include appropriate behavioral assessment. [1][2]
A hypothetical distinction
Imagine an adult study is positive and a child study is null. Extending the adult result to children would discard relevant evidence.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product. - N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.